Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization

Autor: Corrêa, João Carlos, Badaró, Roberto, Bumroongkit, Chaiwat, Mera, Jorge Raúl, Dolmann, Alberto Lorenzo, Juárez Martínez, Luis Guillermo, Mayrinck, Lusane Romero, Tamez, Ricardo, Yang, Joanna Y
Zdroj: In Clinical Therapeutics 2003 25(5):1453-1468
Databáze: ScienceDirect
Externí odkaz: